Showing results (1241-1250 of 1,323) with videos related to

Sort By:
Pageof 133
MMWR. Morbidity and Mortality Weekly Report|November 21, 2014
Ebola epidemic--Liberia, March-October 2014Tolbert Nyenswah, Miatta Fahnbulleh, Moses Massaquoi, et al.
Biorxiv : the Preprint Server for Biology|November 30, 2021
Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activitiesYaozong Chen, Lulu Sun, Irfan Ullah, et al.
Cancer Medicine|October 2, 2025
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple MyelomaNiels W C J van de Donk, Ajai Chari, Thomas Martin, et al.
Emerging Infectious Diseases|March 14, 2017
Ebola Virus RNA in Semen from an HIV-Positive Survivor of EbolaLawrence J Purpura, Emerson Rogers, April Baller, et al.
Science Advances|July 20, 2022
Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activitiesYaozong Chen, Lulu Sun, Irfan Ullah, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activityLorie Marchitto, Jonathan Richard, Jérémie Prévost, et al.
Plant Disease|August 14, 2023
Characterization of QoI-Fungicide Resistance in Cercospora Isolates Associated with Cercospora Leaf Blight of Soybean from the Southern United StatesBishnu K Shrestha, Brian M Ward, Tom W Allen, et al.
Frontiers in Immunology|January 24, 2022
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1sWilliam D Tolbert, Dung N Nguyen, Marina Tuyishime, et al.
The New England Journal of Medicine|October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in LiberiaStephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
Plos Pathogens|June 5, 2026
HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibitionAugust Myers, Monika Chandravanshi, Leanne S Whitmore, et al.
Pageof 133